DeepRhythmAI vs EchoGo Amyloidosis
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
DeepRhythmAI specializes in detecting and classifying a wide range of cardiac arrhythmias using ECG data, aiming to improve the efficiency and accuracy of ECG reporting. Conversely, EchoGo Amyloidosis is designed for the early detection of cardiac amyloidosis by analyzing echocardiogram video clips. While both are FDA-cleared AI tools in cardiology, they address distinct diagnostic challenges with different input modalities.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
DeepRhythmAI is designed for the detection and classification of various cardiac arrhythmias from ECG data. In contrast, EchoGo Amyloidosis is an AI-powered screening tool focused on the early detection of cardiac amyloidosis from echocardiogram video clips.
DeepRhythmAI analyzes ECG data, and it is device-agnostic, integrating with various ECG devices. EchoGo Amyloidosis, on the other hand, requires echocardiogram video clips for its AI-powered analysis.
DeepRhythmAI is reported to reduce missed arrhythmia diagnoses by 14x to 114x and increase workflow efficiency by up to 65%. EchoGo Amyloidosis boasts a high diagnostic accuracy with 85% sensitivity and 93% specificity for identifying suspected cardiac amyloidosis, performing consistently across various CA subtypes.
DeepRhythmAI's pricing is listed as 'enterprise,' with specific details unknown. EchoGo Amyloidosis provides detailed pricing: $1,000 per analysis for inpatient use (Medicare-covered) and $285 per analysis for outpatient use (covered by Medicare and select commercial insurers).
DeepRhythmAI offers an API for integration with various ECG devices and third-party software, aiming to streamline clinical workflows. EchoGo Amyloidosis is designed for seamless integration with existing clinical workflows and IT infrastructure, including PACS, DICOM, and HL7.